The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but ...

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways: IAVI's Lassa vaccine candidate rVSVΔG-LASV-GPC has an acceptable safety profile and ...

Britain on Wednesday became the first country in the world to approve the COVID-19 vaccine developed by U.S. drugmaker Pfizer and its German partner BioNTech , , and said it will be rolled out from ...

Many London trials offer compensation, though amounts vary significantly. Phase I trials with healthy volunteers often require participants to pay several thousand pounds for studies involving ...

A study published in The Lancet Child & Adolescent Health looks at myocarditis and vascular and inflammatory diseases after COVID-19 infection and vaccination in children. Prof Saidi (Sam) Mohiddin, ...

Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.

Two years later, those treatments have thrust Metsera to the centre of a fierce takeover battle, with Ozempic maker Novo Nordisk and Pfizer willing to pay up to $10bn for the company. Both once again ...

Experts have long sounded the alarm over myocarditis, an extremely rare complication of the vaccine that causes inflammation ...

Vaccination against COVID-19 helps reduce long COVID risk in adolescents after their first SARS-CoV-2 infection, a new study finds.

AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...

President Donald Trump has received updated flu and COVID-19 booster shots in preparation for upcoming travel, the president’s physician announced Oct. 10. Sean P. Barbabella, a U.S. Navy captain, ...